Make Plans to Join us...
Thursday, March 30
in Hummelstown, PA
William H. & Marion C. Alexander Family LibraryMeeting Rooms A & B
200 West Second Street, Hummelstown, PA 17036
(5 minutes from Hershey, PA)
Doors Open at 10am | Registration at 10:15am | First Speaker at 10:45am
Agenda | RSVP | Directions | Bios
1000am
Breakfast and Registration
1030am
Welcome and Announcements
1045am
"Pros and Cons of Rapid
Infectious Disease Testing"
Norman Moore, PhD | Bio
Director, Scientific Affairs for Infectious Diseases, Alere
Many tests are available that can give diagnostic information in minutes which can aid in directing therapy. One of the more common rapid options is lateral flow technology which is built on antibody/antigen interactions. Additionally, newer molecular amplification options are now allowing testing to become more rapid. Rapid results allow for better directed therapy. Learning objectives will include understanding the basis for how the immunological tests work; understanding the pros and cons of rapid infectious disease testing; and defining what rapid test results mean in multiple disease states
1145am
Key Benefits or Molecular Testing
Alere – Vendor Presentation – KC McGrath
1200pm
KEYPOCC Business Meeting
1230pm
Visit Vendors and Lunch
130pm
“Challenges in Expanding the Number of POC Sites Within a Patient-Centered Health System”
Peggy A. Mann, M.S., MT(ASCP) | Bio
Ambulatory POCC and Program Manager
University of Texas Medical Branch, Galveston, TX
This presentation will include the following learning objectives and conclude with a Q&A session. Learning objectives will include describing the expanding role of POCT into diverse clinical settings for patient centered care; identifying POCT clinical considerations and managerial challenges; and discussing tools and strategies for enhancing POCT quality practices, regulatory compliance and multidisciplinary collaboration.
230pm
Break and Visit Vendors
245pm
Point of Care Testing Supports
a Patient-Centric Approach in
the Ambulatory Setting
Paul Morris | Bio
Medical Director, Department of Regulatory Affairs
Abbott Point of Care
345pm
Closing Comments
400pm
Meeting adjourned - P.A.C.E. Forms
By Email
Address
William H. & Marion C. Alexander Family Library
200 W 2nd StHummelstown, PA 17036
Phone: (717) 566-0949Peggy A. Mann, M.S., MT(ASCP) | Bio
Ambulatory POCC and Program Manager
University of Texas Medical Branch, Galveston, TX
Peggy Mann works for the University of Texas Medical Branch. She is the Ambulatory POCC, a Program Manager, and the laboratory liaison. Peggy’s clinic oversight extends to 400 miles from the medical school campus, includes clinics related to 3 campuses and covers more than 100 clinics. She’s been with UTMB for 35 years.
Professionally volunteering with AACC and CLSI, Peggy is the current AACC CPOCT Executive Board Secretary. She is a member of the new AACC CLS Council for a three year term. With CLSI, she is the CLSI Vice-Chair of the POC Expert Panel and serves on a five year CLSI-CDC Project studying ‘Improving the Impact of Laboratory Practice Guidelines’. For the current CLSI Document Development Committee, “Patient and Sample Identification”, which will take a guideline document into a Standard document, Peggy chairs review and revision of the POC-related section of the document.
Peggy takes an active role in two POCC Groups, the Texas Gulfcoast and the Southwest Regional POCC Groups and is active in the AACC Texas Section.
Peggy’s awards include: the 2008 POCC of the Year, the 2012 Southwest Regional POCC of the Year, the 2014 Lifetime Achievement Award for Coordinators of Point-of-Care Testing and a 2016 CLSI Excellence in Standards Development Award.
Peggy received her B.S. from Pennsylvania State University and her M.S. from the University of Houston.
Norman Moore, PhD
Director, Scientific Affairs for Infectious Diseases, Alere
Dr. Moore received his Bachelors Degree in biology and philosophy from Dartmouth College and his PhD in microbiology from the University of New Hampshire. While at Digene Diagnostics, he worked on an assay for human papillomavirus, the etiological agent for cervical cancer. At GeneTrak Systems, he commercialized a test for Salmonella in the food industry. He went to work for Binax where as a senior scientist, he developed the first ever rapid tests for Legionella and S. pneumoniae, both of which are now recommended by the Infectious Disease Society of America for use in severe pneumonia cases.
He became the R&D director where he developed tests for diseases such as influenza and RSV. Binax was acquired by Alere, formerly Inverness Medical where he then took on the role of scientific affairs for infectious diseases. He has served on multiple NIAID grant committees, the CDC guideline group for rapid influenza testing, and the Clinical Laboratory Standards Institute guideline committee for point-of-care infectious disease He currently has six patents and numerous publications and presentations.
Dr. Moore received his Bachelor’s Degree in biology and philosophy from Dartmouth College and his PhD in microbiology from the University of New Hampshire. Among other assays, he developed the first ever rapid tests for Legionella and S. pneumoniae, both of which are now recommended by the Infectious Disease Society of America. After being an R&D director for many years, he took the role of Director of Scientific Affairs where he works with the medical community.
He has served on multiple NIAID grant committees, the CDC guideline group for rapid influenza testing, the College of American Pathology’s and Clinical Laboratory Standards point-of care committees, and CLSI’s infectious disease guideline writing committee. He currently has six patents and numerous publications and presentations.
Paul Morris
Medical Director in the Department of Regulatory Affairs, Abbott Point of Care
Paul Morris joined Abbott Point of Care in April, 2015 as the Medical Director in the Department of Regulatory Affairs. He provides medical support to the quality, compliance, and clinical and regulatory affairs team for pre- and on-market programs.
Paul has 13 years of experience as a Medical and Laboratory Director in the Blood and Tissue Banking Industry; and was an Assistant Professor at the University of Miami.
He received his M.D. from Boston University, and completed a Pathology Residency at Duke University and Transfusion Medicine Fellowship at the University of North Carolina. Dr. Morris is board-certified in Clinical Pathology and Transfusion Medicine by the American Board of Pathology.
Return to PointofCare.net Home Page • Last updated: 03/20/2017 • Questions: editor@pointofcare.net
